1. P720: PROACTIVE DASATINIB DOSE REDUCTION IN THE ALLG CML 12 DIRECT STUDY BASED ON TROUGH LEVELS MINIMISE TOXICITY AND PRESERVE EFFICACY. (23rd June 2022) Authors: Yeung, D.; Grigg, A.; Shanmuganathan, N.; Soltenbeck, A.; White, D.; Branford, S.; Viiala, N.; Rowlings, P.; Mills, A.; Shortt, J.; Tiley, C.; Ross, D.; Kipp, D.; Harrup, R.; Cunningham, I.; Kwan, J.; Eek, R.; Mutsando, H.; Tan, K.-S.; Burbury, K. Other Names: other. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗